[
  {
    "ts": null,
    "headline": "Moderna (NasdaqGS:MRNA) Faces Legal Spotlight Affecting Investor Sentiment with -8% Dip Over Last Month",
    "summary": "Recent legal challenges have put Moderna (NasdaqGS:MRNA) in a spotlight, as Genevant Sciences and Arbutus Biopharma Corporation have filed lawsuits alleging patent infringements related to lipid nanoparticle technology across numerous countries, affecting products like Spikevax®. This ongoing legal tussle has impacted investor sentiment, contributing to the company's share price decline of 8% over the month. Compounding this, general market trends showed volatility with a 3% decline. Despite...",
    "url": "https://finnhub.io/api/news?id=2487006f65e0cfadef972b3a5b6897ba2bd670d71c64f70e0aaa6cf0d92fc00a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743530249,
      "headline": "Moderna (NasdaqGS:MRNA) Faces Legal Spotlight Affecting Investor Sentiment with -8% Dip Over Last Month",
      "id": 133655375,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Recent legal challenges have put Moderna (NasdaqGS:MRNA) in a spotlight, as Genevant Sciences and Arbutus Biopharma Corporation have filed lawsuits alleging patent infringements related to lipid nanoparticle technology across numerous countries, affecting products like Spikevax®. This ongoing legal tussle has impacted investor sentiment, contributing to the company's share price decline of 8% over the month. Compounding this, general market trends showed volatility with a 3% decline. Despite...",
      "url": "https://finnhub.io/api/news?id=2487006f65e0cfadef972b3a5b6897ba2bd670d71c64f70e0aaa6cf0d92fc00a"
    }
  },
  {
    "ts": null,
    "headline": "Is Moderna, Inc. (MRNA) the Best Gene-Editing Stock to Buy?",
    "summary": "We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other best gene-editing stocks to buy. Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or […]",
    "url": "https://finnhub.io/api/news?id=fdc07dabc8e047bd45cfb5cd1bb1d1c7f79cea7c139789c8a15b8964b83aac56",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743525762,
      "headline": "Is Moderna, Inc. (MRNA) the Best Gene-Editing Stock to Buy?",
      "id": 133655376,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other best gene-editing stocks to buy. Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or […]",
      "url": "https://finnhub.io/api/news?id=fdc07dabc8e047bd45cfb5cd1bb1d1c7f79cea7c139789c8a15b8964b83aac56"
    }
  },
  {
    "ts": null,
    "headline": "Biotech stocks slide as Marks resignation seen being negative for sector",
    "summary": "Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug Administration’s Center for Biologics Evaluation and Research, Peter Marks. RBC Capital says the development is “not good for the biotech industry even beyond vaccines.” Voicing a similar opinion, BMO Capital told investors this morning that it sees the news as a “significant negative” for the biopharma and biotech sectors. “NOT GOOD” FOR BIOTECH SECTOR: RBC Capit",
    "url": "https://finnhub.io/api/news?id=254d158cbf2c958ffa39dd784453958618f4931103736807bbadab76abc44dcf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743522637,
      "headline": "Biotech stocks slide as Marks resignation seen being negative for sector",
      "id": 133645467,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug Administration’s Center for Biologics Evaluation and Research, Peter Marks. RBC Capital says the development is “not good for the biotech industry even beyond vaccines.” Voicing a similar opinion, BMO Capital told investors this morning that it sees the news as a “significant negative” for the biopharma and biotech sectors. “NOT GOOD” FOR BIOTECH SECTOR: RBC Capit",
      "url": "https://finnhub.io/api/news?id=254d158cbf2c958ffa39dd784453958618f4931103736807bbadab76abc44dcf"
    }
  },
  {
    "ts": null,
    "headline": "3 Market Predictions For April",
    "summary": "Discover three key market predictions for April as a new trading quarter begins. Click for my look at the current state of the markets and what may be coming.",
    "url": "https://finnhub.io/api/news?id=e3788b44404b7d2462a26e1967633aca172223b777dd681a1527190adadbfe83",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743509759,
      "headline": "3 Market Predictions For April",
      "id": 133647888,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/483661187/image_483661187.jpg?io=getty-c-w1536",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "Discover three key market predictions for April as a new trading quarter begins. Click for my look at the current state of the markets and what may be coming.",
      "url": "https://finnhub.io/api/news?id=e3788b44404b7d2462a26e1967633aca172223b777dd681a1527190adadbfe83"
    }
  },
  {
    "ts": null,
    "headline": "5 Things to Know Before the Stock Market Opens",
    "summary": "News of the day for April 1, 2025",
    "url": "https://finnhub.io/api/news?id=30a3686c16bb78908adb811b0ad4fbb7ff7afdd52ec7b13c2e91bdae1d9379b3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743507917,
      "headline": "5 Things to Know Before the Stock Market Opens",
      "id": 133646177,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "News of the day for April 1, 2025",
      "url": "https://finnhub.io/api/news?id=30a3686c16bb78908adb811b0ad4fbb7ff7afdd52ec7b13c2e91bdae1d9379b3"
    }
  },
  {
    "ts": null,
    "headline": "Trending tickers: Tesla, Moderna, Newsmax, Johnson & Johnson and Travis Perkins",
    "summary": "The latest investor updates on stocks that are trending on Tuesday.",
    "url": "https://finnhub.io/api/news?id=37c7aacd6edd990b639e66860f7b4b24fc51b6b6fb7f791287597fcb15bed199",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743506836,
      "headline": "Trending tickers: Tesla, Moderna, Newsmax, Johnson & Johnson and Travis Perkins",
      "id": 133645184,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The latest investor updates on stocks that are trending on Tuesday.",
      "url": "https://finnhub.io/api/news?id=37c7aacd6edd990b639e66860f7b4b24fc51b6b6fb7f791287597fcb15bed199"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: green light from Australia for RSV mRNA vaccine",
    "summary": "Moderna reports that the Australian Therapeutic Goods Administration has approved mRESVIA , its mRNA vaccine against respiratory syncytial virus in adults aged 60 and over.mRESVIA is the first mRNA...",
    "url": "https://finnhub.io/api/news?id=59f79a1e007efdf620e622b9b38800bf2931b37de84dfe3606d6382a95ea546a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743500188,
      "headline": "Moderna: green light from Australia for RSV mRNA vaccine",
      "id": 133636216,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna reports that the Australian Therapeutic Goods Administration has approved mRESVIA , its mRNA vaccine against respiratory syncytial virus in adults aged 60 and over.mRESVIA is the first mRNA...",
      "url": "https://finnhub.io/api/news?id=59f79a1e007efdf620e622b9b38800bf2931b37de84dfe3606d6382a95ea546a"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street analysts urge Trump to ‘re-evaluate’ RFK Jr.’s role as head of HHS",
    "summary": "Wall Street analysts urge Trump to ‘re-evaluate’ RFK Jr.’s role as head of HHS",
    "url": "https://finnhub.io/api/news?id=d1e8c1a204e18524d3fa5c1daf483c9a6ed3eca9d3a6589d0d9a040e794989d0",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743492240,
      "headline": "Wall Street analysts urge Trump to ‘re-evaluate’ RFK Jr.’s role as head of HHS",
      "id": 133654528,
      "image": "",
      "related": "MRNA",
      "source": "MarketWatch",
      "summary": "Wall Street analysts urge Trump to ‘re-evaluate’ RFK Jr.’s role as head of HHS",
      "url": "https://finnhub.io/api/news?id=d1e8c1a204e18524d3fa5c1daf483c9a6ed3eca9d3a6589d0d9a040e794989d0"
    }
  },
  {
    "ts": null,
    "headline": "Trump Wants Made in America, Musk Wants Robots. That’s a Problem for U.S. Jobs and 5 Other Things to Know Today.",
    "summary": "Trump Wants Made in America, Musk Wants Robots. That’s a Problem for U.S. Jobs and 5 Other Things to Know Today.",
    "url": "https://finnhub.io/api/news?id=dd82e0bb95fc6d0020e0a1f85e0a4aba1c5e41fbbf9aaff9a1024bdb3f767d3d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743491580,
      "headline": "Trump Wants Made in America, Musk Wants Robots. That’s a Problem for U.S. Jobs and 5 Other Things to Know Today.",
      "id": 134146724,
      "image": "",
      "related": "MRNA",
      "source": "MarketWatch",
      "summary": "Trump Wants Made in America, Musk Wants Robots. That’s a Problem for U.S. Jobs and 5 Other Things to Know Today.",
      "url": "https://finnhub.io/api/news?id=dd82e0bb95fc6d0020e0a1f85e0a4aba1c5e41fbbf9aaff9a1024bdb3f767d3d"
    }
  },
  {
    "ts": null,
    "headline": "Watch These Moderna Price Levels as Stock Sinks to 5-Year Low",
    "summary": "Moderna shares may remain under the microscope on Tuesday after sinking to a five-year low following news that the Food and Drug Administration’s top vaccine official has resigned. Watch these key price levels on the weekly chart.",
    "url": "https://finnhub.io/api/news?id=c559fd638233b228f72964feafaf622f5aafd768f96689d4f5ebcd774bcc22d2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743474572,
      "headline": "Watch These Moderna Price Levels as Stock Sinks to 5-Year Low",
      "id": 133633295,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna shares may remain under the microscope on Tuesday after sinking to a five-year low following news that the Food and Drug Administration’s top vaccine official has resigned. Watch these key price levels on the weekly chart.",
      "url": "https://finnhub.io/api/news?id=c559fd638233b228f72964feafaf622f5aafd768f96689d4f5ebcd774bcc22d2"
    }
  }
]